UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii41-vii48

2012

Volltextzugriff (PDF)

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii33-vii40

2012

Volltextzugriff (PDF)

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Annals of oncology, 2009-06, Vol.20 (6), p.985-992

2009

Volltextzugriff (PDF)

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Annals of oncology, 2008-09, Vol.19 (9), p.1592-1599

2008

Volltextzugriff (PDF)

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy

Cancer, 2001-07, Vol.92 (1), p.71-76

2001

Volltextzugriff (PDF)

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2040-2049

1997

Volltextzugriff (PDF)

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

European journal of cancer (1990), 2008-03, Vol.44 (4), p.528-538

2008

Volltextzugriff (PDF)

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Journal of clinical oncology, 2011-05, Vol.29 (13), p.1715-1721

2011

Volltextzugriff (PDF)

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007

Annals of oncology, 2008-06, Vol.19 (suppl-6), p.vi1-vi8

2008

Volltextzugriff (PDF)

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Annals of oncology, 2007-06, Vol.18 (suppl-7), p.vii1-vii10

2007

Volltextzugriff (PDF)

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Annals of oncology, 2006-06, Vol.17 (suppl-6), p.vi13-vi18

2006

Volltextzugriff (PDF)

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Annals of surgery, 2012-03, Vol.255 (3), p.534-539

2012

Volltextzugriff (PDF)

Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors

Journal of the American College of Surgeons, 1995-02, Vol.180 (2), p.213-219

1995

Volltextzugriff (PDF)

New directions in the treatment of colorectal cancer: a look to the future

European journal of cancer (1990), 2000-03, Vol.36 (5), p.559-566

2000

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for metastatic colon cancer : A cautionary note

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9073-9078

2005

Volltextzugriff (PDF)

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2757-2763

1995

Volltextzugriff (PDF)

Prolonged survival after resection of pancreatoblastoma and synchronous liver metastases in an adult

Hepato-gastroenterology, 2001-09, Vol.48 (41), p.1340

2001

Volltextzugriff (PDF)

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study

Annals of oncology, 1997-06, Vol.8 (6), p.575-581

1997

Volltextzugriff (PDF)

Liver metastases from colorectal cancer: the turning point

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1442-1445

2002

Volltextzugriff (PDF)

Carcinoma of the oesophagus

British journal of cancer, 2001-05, Vol.84 Suppl 2 (s2), p.61-64

2001

Volltextzugriff (PDF)

Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU

Annals of oncology, 1993, Vol.4 Suppl 2, p.21-28

1993

Volltextzugriff (PDF)

Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum

Journal of the American College of Surgeons, 1995-10, Vol.181 (4), p.303-310

1995

Volltextzugriff (PDF)

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study

Annals of oncology, 2008-09, Vol.19 (9), p.1592-1599

2008

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

ThemaCombined Modality Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(81)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(81)
Female
(42)
Male
(42)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Middle Aged
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Oncology
(31)
Adult
(28)
Aged
(28)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Chemotherapy, Adjuvant
(18)
Fluorouracil - Administration & Dosage
(17)
Neoplasm Staging
(15)
Liver Neoplasms - Secondary
(13)
Prognosis
(13)
Pharmacology. Drug Treatments
(12)
Treatment Outcome
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors

New directions in the treatment of colorectal cancer: a look to the future

Neoadjuvant chemotherapy for metastatic colon cancer : A cautionary note

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer

Prolonged survival after resection of pancreatoblastoma and synchronous liver metastases in an adult

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study

Liver metastases from colorectal cancer: the turning point

Carcinoma of the oesophagus

Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU

Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II–III colorectal cancer: a multicentre randomised controlled phase III trial

Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study

Aktive Filter

Suchergebnisse filtern